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It is well established that the majority of murine fetal thymocytes (day 15 of gestation)
express receptors for interleukin 2 (IL-2), but the functional significance of these IL-2 recep-
tors (IL-2Rs) is not clear. In situ hybridization data show a developmentally regulated
expression of IL-2 and IL-2R mRNA. IL-2 binding studies were performed on fetal thymo-
cytes and the results show the presence of both high (kD 20 pM) and low (kD 10 nM)
affinity IL-2Rs. These IL-2Rs are indeed functional: intact fetal thymic lobes (but not cell
suspensions) cultured in IL-2 exhibited an in vitro proliferative response at 20 pM of IL-2,
corresponding with the presence of a functional high-affinity IL-2R on fetal thymocytes. The
IL-2-dependent growth was primarily observed in the IL-2R + thymic subset, which contains
the CD3-/CD4-/CD8- precursor thymocytes. Furthermore, in vitro blocking of IL-2 in
intact fetal thymic lobes resulted in a reduction in the cell yield, which predominantly
affected the expansion of the immature CD3-/CD4-/CD8-thymocytes. Our findings
strongly support the concept that the IL-2/IL-2R pathway is responsible for the proliferation
of precursor cells within the fetal thymus.
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INTRODUCTION
It is now accepted that interleukin 2 (IL-2) is respon-
sible for promoting the growth of mature T cells
subsequent to their activation by antigen (Smith,
1984). By comparison, the role of IL-2 in directing
the proliferation of immature T cells remains con-
troversial, particularly as proliferation occurs maxi-
mally in the developing thymus before expression of
the T-cell antigen receptor complex (TCR). By day 15
of murine fetal development, a majority of fetal
thymocytes (>60%) express membrane receptors
for IL-2, as evaluated by staining with monoclonal
antibodies (mAbs) reactive with the IL-2 receptor
(IL-2R) (Raulet, 1985; Habu et al., 1985; von
Boehmer et al., 1985; Penit and Vasseur, 1989). Fetal
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thymocytes also have the capability to produce IL-2
when stimulated in vitro (Ceredig, 1986; Tetori et
al., 1988a). Therefore, it is plausible to hypothesize
that the IL-2/IL-2R pathway is somehow involved in
T-cell development, providing growth and/or differ-
entiation signals. However, several reports have
questioned the functional status of the IL-2R on fetal
thymocytes (Ceredig et al., 1985; Lowenthal et al.,
1986), in part because the mAbs used to detect the
IL-2R identify only the p55 chain of the IL-2R
(Saragovi and Malek, 1987; Teshigawara et al.,
1987). This chain binds IL-2 with low affinity and
cannot deliver the growth signal to the cell in the
absence of the p75 chain; both chains are required
to form functional high-affinity IL-2Rs (Smith, 1988).
The first and most crucial question regarding the
possible role of the .IL-2/ILo2R pathway in T-cell
development is whether the IL-2R expressed on fetal
thymocytes is indeed functional. Answers to this
question so far have been diverse. Although several
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studies report that murine fetal thymocytes do not
respond to IL-2 by proliferation (Raulet, 1985; Habu
et al., 1985; von Boehmer et al., 1985), other studies
show that both murine and human fetal thymocytes
exhibit IL-2-promoted proliferation (Hardt et al.,
1985, 1986; Toribio et al., 1988; Ceredig et al., 1989;
Toribio et al., 1989; Watson et al., 1989). The con-
troversy is further fueled by the observation that the
affinity of IL-2Rs on resting double-negative (CD4-/
CD8-) adult thymocytes (regarded as a model for
fetal thymocytes) is lower than that reported for IL-
2Rs on mature activated T cells (Ceredig et al., 1985;
Lowenthal et al., 1986). Additionally, the IL-2Rs on
these adult double-negative thymocytes cannot
internalize IL-2. Even more compelling is the lack of
any data showing that adequate concentrations of
IL-2 are produced in the thymus. Given these con-
siderations, we were intrigued by the observation
that mAbs against the IL-2R p55 chain have dra-
matic inhibitory effects on fetal thymocyte matura-
tion and proliferation (Jenkinson et al., 1987; Tentori
et al., 1988b).
In view of all these data, we sought to determine
directly whether both IL-2 and functional IL-2R are
expressed during T-cell development, and whether
fetal thymocytes can proliferate in response to the
low concentrations of IL-2 predicted to saturate
high-affinity IL-2Rs. Our results indicate that IL-2
and IL-2R mRNA undergo developmentally regu-
lated expression, and that the IL-2Rs expressed in
fetal thymocytes are functional high-affinity recep-
tors. The present data also suggest a role for IL-2
during the expansion of precursor thymocytes, thus
supporting the concept that the IL-2/IL-2R pathway
is involved in thymocyte maturation.
RESULTS AND DISCUSSION
Developmental Expression of IL-2 and IL-2R mRNA
We examined the kinetics and population distribu-
tion of both IL-2 and IL-2R mRNA expression
during fetal ontogeny. Using a quantitative method
of in situ hybridization, we demonstrated that IL-2
and IL-2R mRNA are expressed simultaneously in a
small fraction of developing murine fetal thymocytes
as early as day 13 of gestation (Fig. 1). Moreover, by
day 15, the majority of fetal thymocytes express
mRNA for IL-2 and IL-2R, and both transcripts dec-
line to low levels by the time of birth. These data
provide the first evidence that fetal thymocytes are
capable of IL-2 production without exogenous
stimulation, and that the entire IL-2/IL-2R system
appears to be developmentally regulated (Carding et
al., 1989). Furthermore, since IL-2 and IL-2Rs are
expressed simultaneously, the data satisfy the min-
imal requirement for implicating IL-2 during fetal
thymic development.
Analysis of High- and Low-Affinity Receptors
Expressed by Fetal Thymocytes
Mature antigen-activated T cells require functional
high-affinity IL-2Rs to respond to the growth-pro-
moting signals provided by IL-2 (Smith, 1988). Since
previous experiments with fetal thymocytes only
examined the expression of nonfunctional, low-
affinity, IL-2 binding sites using anti-p55 mAbs
(Habu et al., 1985; Raulet, 1985; Penit and Vasseur,
1989), we performed equilibrium binding assays
with [125-I]-IL-2 to monitor both high- and low-
affinity binding sites. Compared with the IL-2-de-
FIGURE 1. In situ hybridization of
fetal thymocytes for IL-2 and IL-2R
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pendent cell line CTLL-2 (Gillis and Smith, 1977)
(Fig. 2c), day 15 (Fig. 2a) and day 16 (Fig. 2b) fetal
thymocytes express remarkably similar IL-2 binding
sites of both high (kD=7-29pM) and low
(kD=7-16 nM) affinity receptors. Thus, the present
results contrast with those previously obtained in
resting adult double-negative thymocytes, in which
higher kD values were observed (Ceredig et al.,
1985; Lowenthal et al., 1986). Failure to detect high-
affinity IL-2 receptors in adult double-negative
thymocytes may have been due to the rigorous iso-
lation procedure of cytotoxic depletion used to
enrich for double-negative thymocytes; such lengthy
methodology may disrupt the stability of the IL-2R
on the remaining double-negative population. In the
present study, IL-2R affinity was examined immedi-
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ately following fetal thymus dissection and cell-
suspension preparation. Therefore, the expression of
high-affinity IL-2Rs by fetal thymocytes suggests
that these receptors may in fact provide a functional
signal during thymic ontogeny.
IL-2-Dependent Response by Fetal Thymocytes
Given the demonstration of IL-2 and IL-2R p55
mRNA transcripts in developing thymocytes, and
having detected high-affinity IL-2R expression, we
next tested for ILo2 responsiveness in vitro. In this
regard, it is noteworthy that former reports failed to
demonstrate a proliferative response by fetal thymo-
cyte single-cell suspensions to IL-2 (Habu et al.,
1985;. Raulet, 1985; von Boehmer et al., 1985). Our
initial attempts to reevaluate the thymocyte
response to IL-2 confirmed these previous findings:
a proliferative response was observed solely at doses
of IL-2 (=5nM) significantly higher than that
required to saturate the high-affinity receptors
(20 pM) (data not shown). However, time-course
studies indicated that a greater response to lower
doses of IL-2 was observed at very early stages after
the disruption of the fetal thymic lobes (data not
shown). Therefore, we argued that an intact thymic
microenvironment might allow for a more physio-
logical IL-2 response (Papiernik et al., 1987; Denning









Kd= 15.8 nM t, 180,775 sites/cell
0 20000 40000 60000 80000
Bound (mol./cell)
FIGURE 2. IL-2 binding assay of fetal thymocytes. Scatchard
plot analysis of [125-I]-rIL-2 equilibrium binding data after
substraction of nonspecific binding for freshly isolated (A) day-15
fetal thymocytes, (B) day-16 fetal thymocytes, or (C) the CTLL IL-
2-dependent cell line.62 J.C. ZOIGA-PFLOCKER et al.
et al., 1988). Indeed, Fig. 3 shows that intact fetal
thymic lobes cultured in IL-2 exhibit an in vitro pro-
liferative response at 20-40 pM of IL-2, a dose corre-
sponding well with the equilibrium dissociation con-
stant (i.e., kD-=7-29pM) of high-affinity IL-2Rs.
Furthermore, the observed increased proliferation
was IL-2 specific as anti-IL-2R (anti-p55) mAbs
blocked the response (Fig. 3b). The necessity of an
intact thymic microenvironment may reflect the
need for cell-cell (thymic stromal cells) interactions
(Papiernik et al., 1987; Denning, et al., 1988; Ceredig
et al., 1989), which may provide signals and/or
other cytokines (IL-7, Watson et al., 1989) necessary
for the proper function of the IL-2R.
Next, we examined to what extent the IL-2-in-
duced increase in [3-H]-thymidine incorporation ref-
lected DNA synthesis in IL-2R + cells. The marked
proliferative response to IL-2 by fetal thymic lobes
affects primarily those thymocytes that express IL-
2Rs, as determined by the increased relative DNA
content of IL-2R+ thymocytes (Table 1). In contrast,
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FIGURE 3. IL-2 response by intact fetal thymus lobes. Intact
fetal thymus lobes were isolated from (A) day 13 or (B) 14
embryos, and placed in culture in a 96-well microtiter plate, at
1 0 0 1 0 0 0 1 0 00 one lobe per well, and cultured for 72 hr. @IL2R indicates the
presence of mAbs specific for the murine IL-2R (Ortega et al., rlL-2 (pM) 1984), at 50/zg/ml.IL2-R IN FETAL THYMUS 63
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ILo2R + 56.5 68.5
IL-2R + high DNA content 36.7 49.2
IL-2R- high DNA content 23.0 16.5
Exp. 2
CD3 -/CD4 -/CD8- 25.3 48.6
CD3 +/CD4 -/CD8- 4.1 6.5
Vy3 +/CD4 -/CD8- 3.3 7.4
Total CD4 -/CD8- 30.8 57.2
CD3 +, dull 35.0 27.8
CD3 +, bright 3.6 8.2
Exp. 3
Total CD4 -/CD8 31.6 55.3
CD3 +/CD4 -/CD8 4.0 6.6
IL-2R + 42.7 48.3
when applied in situations where the thymic micro-
environment is intact (Jenkinson et al., 1987; Tetori
et al., 1988b): it is only under the latter conditions
that expression of a high-affinity IL-2R translates
into the presence of functional IL-2Rs, and that pro-
liferation of several early thymic subsets can be
achieved with IL-2. Events such as normal prolifera-
tion and differentiation have been shown to occur in
vitro only when an intact fetal lobe is placed into
culture (Ceredig, 1988; Ceredig et al., 1989), thus
emphasizing the importance of an intact thymic mic-
roenvironment for the proper cellular interactions
and signals to take place. Blocking the IL-2R
pathway may delay these early events, thus
explaining the anti-IL-2R-mediated alteration in
T-cell development (Jenkinson et al., 1987; Tentori et
al., 1988b).
Phenotypic analysis of intact day-14 fetal thymic lobes responding to
IL-2 (50 pM) in vitro following 4-day incubation. 1L-2R + cells with high
DNA content were Thyol+, and fetal thymic lobes cultured in IL-2 also
showed a marked increase in forward light scatter (data not shown). In
both groups, an equivalent number of cells was recovered per lobe. The
percent (%) positive indicates positive fluorescence over background,
stained with an irrelevant antibody. Results shown are representative of
five independent experiments.
bDay 14 FTOC, 4-day culture.
Stimulation with IL-2 also increases, most mar-
kedly, the absolute and relative number of CD3-/
CD4-/CD8-(triple-negative, TN) cells, which dou-
bles following incubation in IL-2 for 96 hr (Table 1).
CD4-/CD8- thymocytes are known to include the
thymic precursor cells (Fowlkes et al., 1985; Scollay
et al., 1988), and their responsiveness to IL-2,
reported here, suggests that IL-2 may be involved in
the proliferation of these intrathymic multipotent
CD3 -/CD4-/CD8- T-cell precursors.
In addition, the relative and absolute number’s of
CD4-/CD8- thymocytes expressing V-gamma-3
TCR (Havran and Allison, 1988) increased after IL-2
stimulation (Table 1), consistent with the recently
reported observation that V-gamma-3+ cells in the
fetal thymus express high levels of IL-2Rs (Havran
and Allison, 1989). An analysis of other V-gamma/
V-delta subsets awaits availability of specific
staining reagents.
The above data establish the conditions under
which IL-2 receptors on fetal thymocytes can deliver
growth-promoting signals, and also resolve the con-
troversy regarding the unresponsiveness of IL-2Rs
expressed on fetal thymocytes. Furthermore, these
data may explain why anti-lL-2R mAbs have such a
dramatic blocking effect on T-cell development
Blockade of the IL-2-Dependent Expansion by
Immature Fetal Thymocytes
The previous results suggest that IL-2 may mediate
the cell proliferation that occurs within the fetal
thymus at a stage when IL-2R expression on TN
(CD3-/CD4-/CD8-) thymocytes is maximal (70%
by day 15; Penit and Vasseur, 1989), and fetal
thymic growth is at an exponential rate (200-fold
from day 14 to day 17; Penit and Vasseur, 1989). All
these events correlate well with the high expression
of IL-2 mRNA and the presence of high-affinity
functional IL-2Rs, thus, implicating a role for IL-2
and its receptor during this stage of thymic expan-
sion.
To investigate whether the binding of IL-2 to its
receptor on precursor cells is necessary in stimu-
lating cell proliferation, an anti-IL-2 mAb ($4B6;
Mossman et al., 1986) was added to intact day-14
fetal thymic organ cultures. Table 2 shows that IL-2
neutralization results in a (---40%) reduction in cell
yield when compared with control cultures of
similar duration. Similar results were previously
reported for IL-2 receptor blocking in organ culture
(Jenkinson et al., 1987). Consistent with our findings
that TN thymocytes exhibit an IL-2-dependent
expansion, it can be expected that an anti-IL-2
blockade might specifically affect this subset most
dramatically. Indeed, Table 3 shows that the relative
and absolute number of immature thymocytes (TN,
and CD5-dull or Lyl-dull; Fowlkes et al., 1985) is
reduced under such conditions. It is noteworthy that
the IL-2R expression in the anti-IL-2-treated group
is obliterated; this is consistent with earlier findings64 J.C. ZOIIGA-PFLOCKER et al.
that show that IL-2 regulates the expression of its
own receptor (Malek and Ashwell, 1985). Therefore,
the observed effects from the anti-IL-2 blocking may
not only reflect an absence of IL-2, but also reflect a
down modulation of the IL-2R, resulting in a defi-
cient IL-2/IL-2R pathway. Whatever the mechanism,
a reduction in cell proliferation and expansion of, the
thymocyte precursor pool is observed.
growth factor for these early immature precursor
thymocytes. Thus, the same lymphokine that is
responsible for the growth promotion of mature
activated T cells also plays as a key role in the pro-
liferation of fetal thymocytes.
MATERIALS AND METHODS
TABLE 2




Exp. I 0.54 0.29
Exp. 2 0.34 0.23
Exp. 3 0.10 0.04
Exp. 4 0.15 0.10
aCellularity and viability of the intact fetal thymic organ cultures were
determined by trypan blue exclusion. Cell recovery corresponds to thymic
lobes pooled from each group (usually 36 lobes/treatment group). Anti-lL-2
($4B6; Mossman et al., 1986) treatment: $4B6 mAb was added daily at
final concentration of 50/g/ml.
bDay 14 FTOC, 9-day culture.
Day 14 FTOC, 6-day culture.
TABLE 3




Timed pregnant C57BL/6 mice were obtained from
The Jackson Laboratory (Bar Harbor, Maine). The
day of observation of a vaginal plug was designated
as day 0 of embryonic development. Pregnant
female mice were killed by cervical dislocation and
embryos dissected from the uterus. Thymus lobes
were dissected from the embryos using a dissecting
microscope and fine watchmaker’s forceps.
Hybridization Probes
All probes used for in situ hybridization were cDNA
fragments cloned into the polylinker of the pGEM1
plasmid using strand procedures. The IL-2 probe
was the 600 bp insert of pMIL-2-20 (Kashima et al.,
1985) and was generously provided by T. Taniguchi.
The murine IL-2R probe consisted of the full-length
cDNA IL2R8 (Miller et al., 1985).
Exp. 1
CD3 -/CD4 -/CD8- 28.3 14.2
IL-2R +/CD4 -/CD8- 15.8 0.3
Exp. 2
Total CD4 -/CD8- 25.4 12.9
CD3 +/CD4 -/CD8- 24.9 14.5
CD3 +/CD4 -/CD8- 2.3 2.7
IL-2R +/CD4 -/CD8- 13.7 1.1
CD5du"/CD8 25.5 16.4
Exp. 3
CD3 -/CD4 -/CD8- 20.7 13.1
IL-2R +/CD4 -/CD8- 9.3 0.5
CD5du"/CD8 19.6 11.0
Phenotypic analysis of intact day-14 fetal thymic lobes after anti-lL-2
($4B6, Mossman et al., 1986) blocking in vitro following a 6-day incu-
bation. The percent (%) positive indicates positive fluorescence over back-
ground, stained with an irrelevant antibody. Results shown are representa-
tive of five independent experiments.
bDay 14 FTOC, 6-day culture.
In situ Hybridization
In situ hybridization was performed by a modifica-
tion of the procedure of Harper et al. (1986), and as
previously described (Pardoll et al., 1987). Briefly,
fetal thymocytes from days 12-17 of gestation
(timed pregnant C57BL/6 mice) were isolated, cyto-.
spun onto slides, and hybridized in situ with the
[35-S]-labeled single-stranded RNA probe for IL-2
and IL-2R (Kashima et al., 1985; Miller et al., 1985).
After a five-day exposure, slides were developed
and counterstained with Giemsa. Grain count per
cell was recorded for between 50 and 150 cells per-
slide. Nonspecific grain counts were determined by
hybridizing under identical conditions with [35-S]-
riboprobes synthesized from the opposite strand.
Taken together, our results show a marked
increase in the percentage of CD3-/CD4-/CD8-
thymocytes following IL-2 stimulation, or a decrease
following IL-2 blocking, establishing IL-2 as a
Radiolabeled IL-2-Binding Assay
The radiolabled rIL-2-binding assays were per-
formed as previously described (Teshigawara et al.,
1987). Briefly, radiolabeled [125-I]-rIL2 was incu-IL2-R IN FETAL THYMUS 65
bated together with cell suspensions (10 cells in
0.2ml DMEM medium supplemented with 10%
FCS), overlayed onto a 0.2-ml mixture of 80% sili-
cone oil and 20% paraffin oil. After a 20-min incu-
bation at 37C, the tubes were centrifuged (8500 g
for 90 s), the tips of the tubes containing the cell
pellet were severed, and the cellbound and free
radioactivity were determined by solid scintillation
counting. The calculated values for the number of
binding sites per cell were derived by Scatchard
analysis of equilibrium binding data after substrac-
tion of nonspecific binding determined in the pres-
ence of 150-fold molar excess of unlabeled rlL-2.
Fetal Thymus Organ Culture
Intact fetal thymus lobes were isolated from day
13-14 embryos and placed in organ culture as previ-
ously described (Mandell and Kennedy, 1978) or
placed in culture in a 96-well microtiter plate, at one
lobe per well. Lobes were incubated in Dulbecco’s
modified Eagle’s medium supplemented with 10%
FCS, 2 mM glutamine, 10 U/ml penicillin, 100/g/ml
streptomycin, 100/zg/ml gentamicin, 0.11 mg/ml
sodium pyruvate, 5xl0-SM 2-ME, and 10mM
Hepes. Cultures were incubated for 72 hr at 37C in
a humidified incubator containing 7.5% CO in air.
Proliferation Assays
Proliferation of fetal thymocytes in thymic organ
culture was measured by incorporation of [3-H]-
thymidine (1/zCi/w411) during a 6-hr pulse. Lobes
were harvested and thoroughly washed with ddH20
and 95% ethanol, prior to processing for liquid
scintillation counting. IL-2 responses were per-
formed in triplicates; each point represents the arith-
metic mean; the STD deviation was 5%.
Fluorescence Staining
Cell suspensions were prepared in HBSS (without
phenol red) containing 1% BSA and 0.1% sodium
azide (FACS buffer). Cells (106/100 1 buffer) were
incubated on ice for 30 min with 10/1 of the appro-
priate antibody, and washed twice after each incu-
bation. Control staining of cells, either with irrele-
vant antibody or with second antibody alone, was
used to obtain background fluorescence values. The
percent positive indicates positive fluorescence over
background. The samples were analyzed on a FACS
440 (Becton and Dickinson, Mountain View, Call-
fornia) interfaced to a PDP 11/24 computer. Data
were collected on 50,000 cells. Reagents used for
direct staining were FITC- or biotin-conjugated anti-
CD3 (Leo et al., 1987), -CD4 (Dialynas et al., 1983),
-CD5 (Ledbetter and Herzenberg, 1979), -CD8
(Ledbetter and Herzenberg, 1979), -IL-2R (Ortega et
.al., 1984), and V-gamma-3 (Havran and Allison,
1988).
The relative DNA content was determined by
fixing the cells (after staining for IL-2R) with ethanol
followed by an incubation with RNase A and finally
with propidium iodine; cells were washed and
analyzed by flow cytometry, as previously reported
(Ashwell et al., 1987).
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